Paul Beavis

19PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion.

Maria N de Menezes, Amanda X Y Chen, Nihali Kulkarni

|Feb 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes.

Junyun Lai, Cheok Weng Chan, Jesse D Armitage

|Jul 03, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Kevin Sek, Amanda X Y Chen, Thomas Cole

|Jul 03, 2025
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.

Amanda X Y Chen, Kah Min Yap, Joelle S Kim

|May 14, 2025
Interleukin-4 modulates type I interferon to augment antitumor immunity.

Hannah V Newnes, Jesse D Armitage, Anthony C Buzzai

|Sep 11, 2024
Intracellular zinc protects tumours from T cell-mediated cytotoxicity.

Emily J Lelliott, Jonathan Naddaf, Katherine Ganio

Pageof 4